Concepedia

Fengqi Jiang

FJ

Statistics

Publications

5

Citations

115

H-Index

5

Active since

2018

Affiliations

Harbin Medical University(Current)

First Affiliated Hospital of Harbin Medical University

Heilongjiang Provincial Hospital

Shanxi Medical University

Fengqi Jiang is an author at Harbin Medical University specializing in tumor biology, cell signaling, and cancer biology.

ORCID

Top concepts

Publications per year

2018–2020

5

Publications

5

Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway

Fengqi Jiang, Yaodong Chen, Shuo Ren et al. · International Journal of Oncology · 2020 · 34 citations · Full text

, , +19

ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway

Yanwei Xing, Shuo Ren, Lianjie Ai et al. · International Journal of Oncology · 2019 · 30 citations · Full text

, , +15

Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway

Shuo Ren, Yanwei Xing, Chengbo Wang et al. · The International Journal of Biochemistry & Cell Biology · 2020 · 24 citations

, , +9

Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinoma

Fengqi Jiang, Shuo Ren, Yaodong Chen et al. · Oncology Reports · 2020 · 17 citations · Full text

, , +16

Identification of critical microRNAs in gastrointestinal stromal tumor patients treated with Imatinib

Z Zhang, Ningni Jiang, Rui Guan et al. · Neoplasma · 2018 · 10 citations · Full text

1–5 of 5